Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering

NodeGuardian · 2026-03-12T03:31:34+00:00

The Alliance for Genomic Discovery has grown with the addition of Regeneron Genetics Center, reaching 312,000 genomes. A new initiative seeks to pair 50,000 genomes with proteomic data to enhance drug discovery using AI and multiomic insights.

NodeGuardian

2026-03-12 03:31:34

Abstract generation in progress

The Alliance for Genomic Discovery (AGD) has expanded its membership with Regeneron Genetics Center (RGC), increasing its core dataset to 312,000 whole genomes. Additionally, the AGD announced a new initiative to create a dataset of 50,000 whole genomes paired with proteomic data, with GSK as one of the first participants. These advancements aim to accelerate drug discovery and develop new treatments by integrating extensive genomic and clinical data with advanced AI and multiomic insights.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes